Partner with HC21

Your route to market

We work with international medtech manufacturers to successfully commercialise products across the UK and Ireland, combining deep local market understanding with proven sales and marketing expertise.

Our model is designed to reduce complexity, protect existing business and support sustainable growth within two of the most established and regulated healthcare markets.

Why partner with us

Entering healthcare markets independently can be time consuming, resource intensive and complex. Partnering with HC21 provides immediate access to infrastructure, expertise and established relationships.

Healthcare 21

Established hospital, procurement and framework access
Experienced local sales and marketing teams
Regulatory and compliance support
Predictable, scalable route to market
Integrated logistics, service and asset management

Selling Direct

What our partners say

"We are excited to collaborate with Healthcare 21, whose expertise and reach in the UK healthcare sector will be instrumental in making Mona Lisa accessible to more clinicians and patients. Together, we aim to set a new standard in prostate cancer diagnostics and care."

"For over 20 years, Healthcare 21 has been a trusted partner built on professionalism and a deep understanding of our products. Their team’s clinical and technical expertise makes them one of our most reliable global partners, and we look forward to our continued collaboration for many years to come."

"CamPROBE® has the potential to offer a safer, well tolerated method for conducting prostate biopsies. This distribution agreement opens the door for wider adoption across the UK, giving more men access to the alternative prostate biopsy approaches they deserve.”

"Our collaboration combines HC21’s deep understanding of the healthcare landscape with Perimed’s four decades of experience in microcirculation and vascular diagnostics. Together, we aim to support improved clinical decision-making and patient outcomes — aligned with the priorities of the UK’s publicly funded healthcare system, the National Health Service (NHS), and broader preventative care initiatives."

"We’re delighted to partner with Aquilant to bring our endoscopic pulsed electric field platform to GI clinicians across the UK. Together, we’re advancing gastrointestinal cancer treatment and improving outcomes for patients."

"Healthcare 21 is our chosen partner for Ireland because they reflect our values and professionalism. Since 2011, we have collaborated to provide a diverse range of medical devices and consumables across all hospital specialties. They are a market leader dedicated to putting the patient at the forefront of everything they do."

"Aquilant has been a reliable, capable and very knowledgeable partner for us for many years. Our cooperation is characterized by mutual trust and we appreciate above all the professionalism of the entire Aquilant team, especially when dealing with complex and challenging customer situations."

What to expect

A structured, transparent model supporting your products from launch through to long term growth.

Sales & marketing

Specialist, therapy focused sales and marketing teams, supported by education and clinical engagement activity to drive responsible adoption.

Logistics & Distribution

Established, scalable infrastructure delivering reliable nationwide coverage.

Asset Management

Robust product and installed base tracking, inventory visibility, and clear commercial reporting to support portfolio control and informed decision making.

Service & Engineering

Local service and engineering teams providing installation, maintenance and after sales support.

Insight & Consultancy

Market insight, pricing guidance and commercial input to support informed decision making.

Transparency & data

Open, collaborative working with partners, supported by clear reporting and shared commercial insight.

Improving commercial and operational outcomes

Beyond market entry, we help partners optimise performance across product lifecycles, sales resources and supply chains.

Portfolio lifecycle management

Supporting the longevity and relevance of medtech portfolios, including mature and high revenue product ranges.

Transparency

By managing established portfolios, we enable partners to focus internal resources on innovation, launches and strategic growth products.

Supply chain rationalisation

Consolidated ordering and invoicing can simplify operations and reduce supply chain workload, providing a more efficient route to market.

Predictable revenue and margin

Consistent ordering and dependable revenue streams supporting long term commercial planning.

Proven experience with medtech manufacturers

We support manufacturers with the transition and management of medtech portfolios across the UK and Ireland, applying long standing commercial, operational and regulatory expertise to protect continuity and value.

Our experience includes:

Portfolio transitions and stewardship

Managing the transfer and ongoing operation of established and non core portfolios, with a focus on maintaining service levels, protecting revenue and supporting long term performance.

Commercial and operational transitions

Supporting the structured transfer of products, assets and operational responsibilities from direct or hybrid models into an outsourced approach, delivered with minimal disruption.

People, contracts and compliance

Experience managing contract novation and TUPE processes, working closely with partner HR, legal and leadership teams to ensure clarity, continuity and compliance with UK and Ireland legislation.

Asset and installed base management

Robust asset tracking, lifecycle oversight and reporting capabilities to support continuity of care, service performance and commercial visibility.

Scale, systems and assurance

Established infrastructure, specialist sales teams and multiple service and logistics locations providing the depth and resilience required to support complex portfolios.

Connected through AddLife

As part of the AddLife group, HC21 is connected into a wider European medtech network, enabling introductions, insight and collaboration where this supports a partner’s broader strategy.

Trusted by our partners

Built for the long term

We focus on collaboration, transparency and sustainable growth, building relationships that evolve over time rather than short term distribution arrangements.

Many of these relationships span decades, reflecting a shared commitment to quality, performance and long term success.

Ready to partner? grow? expand? accelerate? scale?

Whether you’re entering the UK and Ireland, optimising an existing route to market, or transitioning an established portfolio, we can support you with the expertise, infrastructure and teams to make it work.